|
Calciphylaxis
|
D002115 |
[Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.
] |
|
Calcitonin
|
D002116 |
[A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.
] |
|
Calcitonin Gene-Related Peptide
|
D015740 |
[A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.
] |
|
Calcitonin Gene-Related Peptide Receptor Antagonists
|
D000077221 |
[Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS.
] |
|
Calcitonin Receptor-Like Protein
|
D058286 |
[A receptor protein that is associated with RECEPTOR ACTIVITY-MODIFYING PROTEINS. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 1 it forms the CALCITONIN GENE-RELATED RECEPTOR. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3 it forms the ADRENOMEDULLIN RECEPTOR.
] |
|
Calcitriol
|
D002117 |
[The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
] |
|
Calcium
|
D002118 |
[A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
] |
|
Calcium Aluminosilicate
|
D000077250 |
[Aluminosilicate salts of calcium, the most common of which are CaAl2Si2O8 and Ca2Al2SiO7; a naturally occurring form in CLAY may be used to treat DIARRHEA.
] |
|
Calcium Carbonate
|
D002119 |
[Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.
] |
|
Calcium Channel Agonists
|
D002120 |
[Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.
] |
|
Calcium Channel Blockers
|
D002121 |
[A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
] |
|
Calcium Channels
|
D015220 |
[Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue.
] |
|
Calcium Channels, L-Type
|
D020746 |
[Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and nonexcitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.
] |
|
Calcium Channels, N-Type
|
D020864 |
[CALCIUM CHANNELS that are concentrated in neural tissue. Omega toxins inhibit the actions of these channels by altering their voltage dependence.
] |
|
Calcium Channels, P-Type
|
D020865 |
[CALCIUM CHANNELS located within the PURKINJE CELLS of the cerebellum. They are involved in stimulation-secretion coupling of neurons.
] |
|
Calcium Channels, Q-Type
|
D020907 |
[CALCIUM CHANNELS located in the neurons of the brain.
] |
|
Calcium Channels, R-Type
|
D020908 |
[CALCIUM CHANNELS located in the neurons of the brain. They are inhibited by the marine snail toxin, omega conotoxin MVIIC.
] |
|
Calcium Channels, T-Type
|
D020747 |
[A heterogenous group of transient or low voltage activated type CALCIUM CHANNELS. They are found in cardiac myocyte membranes, the sinoatrial node, Purkinje cells of the heart and the central nervous system.
] |
|
Calcium Chelating Agents
|
D065096 |
[Substances that bind to and sequester CALCIUM ions.
] |
|
Calcium Chloride
|
D002122 |
[A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.
] |
